| References |
|
|
Abelson JF,
Kwan KY,
O'Roak BJ et al.
(2005)
Sequence variants in SLITRK1 are associated with Tourette's syndrome.
Science
310:
317–320.
|
|
|
Adams BD,
Furneaux H and
White BA
(2007)
The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines.
Molecular Endocrinology
21:
1132–1147.
|
|
|
Allamand V,
Richard P,
Lescure A et al.
(2006)
A single homozygous point mutation in a 3¢-untranslated region motif of selenoprotein N mRNA causes SEPN1-related myopathy.
EMBO Reports
7:
450–454.
|
|
|
Beetz C,
Schüle R,
Deconinck T et al.
(2008)
REEP1 mutation spectrum and genotype/phenotype correlation in hereditary spastic paraplegia type 31.
Brain
131:
1078–1086.
|
|
|
Bennett CL,
Brunkow ME,
Ramsdell F et al.
(2001)
A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAAAAUGAA) leads to the IPEX syndrome.
Immunogenetics
53:
435–439.
|
|
|
Chen K,
Song F,
Calin GA et al.
(2008)
Polymorphisms in microRNA targets: a gold mine for molecular epidemiology.
Carcinogenesis
29:
1306–1311.
|
|
|
Chien YL,
Liu CM,
Fann CS et al.
(2009)
Association of the 3¢ region of COMT with schizophrenia in Taiwan.
Journal of the Formosan Medical Association
108:
301–319.
|
|
|
Chin LJ,
Ratner E,
Leng S et al.
(2008)
A SNP in a let-7 microRNA complementary site in the KRAS 3¢ untranslated region increases non-small cell lung cancer risk.
Cancer Research
68:
8535–8540.
|
|
|
Chuzhanova N,
Cooper DN,
Férec C and
Chen JM
(2007)
Searching for potential microRNA-binding site mutations amongst known disease-associated 3¢ UTR variants.
Genomic Medicine
1:
29–33.
|
|
|
Daughters RS,
Tuttle DL,
Gao W et al.
(2009)
RNA gain-of-function in spinocerebellar ataxia type 8.
PLoS Genetics
5(8):
e1000600.
|
|
|
Egli RJ,
Southam L,
Wilkins JM et al.
(2009)
Functional analysis of the osteoarthritis susceptibility-associated GDF5 regulatory polymorphism.
Arthritis and Rheumatism
60:
2055–2064.
|
|
|
Harteveld CL,
Losekoot M,
Haak H,
Heister GA et al.
(1994)
A novel polyadenylation signal mutation in the 2-globin gene causing -thalassaemia.
British Journal of Haematology
87:
139–143.
|
|
|
He H,
Jazdzewski K,
Li W et al.
(2005)
The role of microRNA genes in papillary thyroid carcinoma.
Proceedings of the National Academy of Sciences of the USA
102:
19075–19080.
|
|
|
Higgs DR,
Goodbourn SE,
Lamb J et al.
(1983)
-Thalassaemia caused by a polyadenylation signal mutation.
Nature
306:
398–400.
|
|
|
Hu Z,
Chen J,
Tian T et al.
(2008)
Genetic variants of miRNA sequences and non-small cell lung cancer survival.
Journal of Clinical Investigation
118:
2600–2608.
|
|
|
Jakubowska A,
Gronwald J,
Górski B et al.
(2007)
The 3¢ untranslated region C>T polymorphism of prohibitin is a breast cancer risk modifier in Polish women carrying a BRCA1 mutation.
Breast Cancer Research Treatment
104:
67–74.
|
|
|
Jensen KP,
Covault J,
Conner TS et al.
(2009)
A common polymorphism in serotonin receptor 1B mRNA moderates regulation by miR-96 and associates with aggressive human behaviors.
Molecular Psychiatry
14:
381–389.
|
|
|
Jones AL,
Holliday EG,
Mowry BJ et al.
(2009)
CTLA-4 single-nucleotide polymorphisms in a Caucasian population with schizophrenia.
Brain, Behavior, and Immunity
23:
347–350.
|
|
|
Kapeller J,
Houghton LA,
Mönnikes H et al.
(2008)
First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor type 3E gene with diarrhea predominant irritable bowel syndrome.
Human Molecular Genetics
17:
2967–2977.
|
|
|
Landi D,
Gemignani F,
Naccarati A et al.
(2008)
Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer.
Carcinogenesis
29:
579–584.
|
|
|
Latronico MV and
Condorelli G
(2009)
MicroRNAs and cardiac pathology.
Nature Reviews. Cardiology
6:
419–429.
|
|
|
López de Silanes I,
Quesada MP and
Esteller M
(2007)
Aberrant regulation of messenger RNA 3¢-untranslated region in human cancer.
Cellular Oncology
29:
1–17.
|
|
|
Losekoot M,
Fodde R,
Harteveld CL et al.
(1991)
Homozygous beta+ thalassaemia owing to a mutation in the cleavage-polyadenylation sequence of the human beta globin gene.
Journal of Medical Genetics
28:
252–255.
|
|
|
Maiti B,
Arbogast S,
Allamand V et al.
(2009)
A mutation in the SEPN1 selenocysteine redefinition element (SRE) reduces selenocysteine incorporation and leads to SEPN1-related myopathy.
Human Mutation
30:
411–416.
|
|
|
Martin MM,
Buckenberger JA,
Jiang J et al.
(2007)
The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microrna-155 binding.
Journal of Biological Chemistry
282:
24262–24269.
|
|
|
Mishra PJ and
Bertino JR
(2009)
MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine.
Pharmacogenomics
10:
399–416.
|
|
|
Mishra PJ,
Humeniuk R,
Mishra PJ et al.
(2007)
A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance.
Proceedings of the National Academy of Sciences of the USA
104:
13513–13518.
|
|
|
Moghadaszadeh B,
Petit N,
Jaillard C et al.
(2001)
Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome.
Nature Genetics
29:
17–18.
|
|
|
Moncini S,
Bevilacqua A,
Venturin M et al.
(2007)
The 3¢ untranslated region of human cyclin-dependent kinase 5 regulatory subunit 1 contains regulatory elements affecting transcript stability.
BMC Molecular Biology
8:
111.
|
|
|
Moseley ML,
Zu T,
Ikeda Ya et al.
(2006)
Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8.
Nature Genetics
38:
758–769.
|
|
|
Prior JF,
Lim E,
Lingam N,
Raven JL and
Finlayson J
(2007)
A moderately severe -thalassemia condition resulting from a combination of the 2 polyadenylation signal (AATAAAAATA--) mutation and a 3.7 Kb gene deletion in an Australian family.
Hemoglobin
31:
173–177.
|
|
|
Ranum LPW and
Cooper TA
(2006)
RNA-mediated neuromuscular disorders.
Annual Reviews in Neurosciences
29:
259–277.
|
|
|
Reamon-Buettner SM,
Cho SH and
Borlak J
(2007)
Mutations in the 3¢-untranslated region of GATA4 as molecular hotspots for congenital heart disease (CHD).
BMC Medical Genetics
8:
38.
|
|
|
Sætrom P,
Biesinger J,
Li SM et al.
(2009)
A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis.
Cancer Research
69:
7459–7465.
|
|
|
Sethupathy P and
Collins FS
(2008)
MicroRNA target site polymorphisms and human disease.
Trends in Genetics
24:
489–497.
|
|
|
Sethupathy P,
Borel C,
Gagnebin M et al.
(2007)
Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3¢ untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes.
American Journal of Human Genetics
81:
405–413.
|
|
|
Sotiriou S,
Gibney G,
Baxevanis AD et al.
(2009)
A single nucleotide polymorphism in the 3¢ UTR of the SNCA gene encoding alpha-synuclein is a new potential susceptibility locus for Parkinson disease.
Neuroscience Letters
461:
196–201.
|
|
|
Tan Z,
Randall G,
Fan J et al.
(2007)
Allele-specific targeting of microRNAs to HLA-G and risk of asthma.
American Journal of Human Genetics
81:
829–834.
|
|
|
Vasilopoulos Y,
Cork MJ,
Murphy R et al.
(2004)
Genetic association between an AACC insertion in the 3¢UTR of the stratum corneum chymotryptic enzyme gene and atopic dermatitis.
Journal of Investigative Dermatology
123:
62–66.
|
|
|
Vasudevan S,
Tong Y and
Steitz JA
(2007)
Switching from repression to activation: microRNAs can up-regulate translation.
Science
318:
1931–1934.
|
|
|
Wang G,
van der Walt JM,
Mayhew G et al.
(2008)
Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha synuclein.
American Journal of Human Genetics
82:
283–289.
|
|
|
Warf MB,
Diegel JV,
von Hippel PH and
Berglund JA
(2009)
The protein factors MBNL1 and U2AF65 bind alternative RNA structures to regulate splicing.
Proceedings of the National Academy of Sciences of the USA
106:
9203–9208.
|
|
|
Wildin RS,
Ramsdell F,
Peake J et al.
(2001)
X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy.
Nature Genetics
27:
18–20.
|
|
|
Williams JW,
Morrison JF and
Duggleby RG
(1979)
Methotrexate, a high-affinity pseudosubstrate of dihydrofolate reductase.
Biochemistry
18:
2567–2573.
|
|
|
Zhang L and
Zhao Y
(2007)
The regulation of Foxp3 expression in regulatory CD4+CD25+T cells: multiple pathways on the road.
Journal of Cellular Physiology
211:
590–597.
|
|
|
Zhang L,
Rao F,
Zhang K et al.
(2007)
Discovery of common human genetic variants of GTP cyclohydrolase 1 (GCH1) governing nitric oxide, autonomic activity, and cardiovascular risk.
Journal of Clinical Investigation
117:
2658–2671.
|
|
|
Züchner S,
Wang G,
Tran-Viet KN et al.
(2006)
Mutations in the novel mitochondrial protein REEP1 cause hereditary spastic paraplegia type 31.
American Journal of Human Genetics
79:
365–369.
|
| Further Reading |
|
|
Chatterjee S and
Pal JK
(2009)
Role of 5¢-and 3¢-untranslated regions of mRNAs in human diseases.
Biology of the Cell
101:
251–262.
|
|
|
Chen JM,
Férec C and
Cooper DN
(2006)
A systematic analysis of disease-associated variants in the 3¢ regulatory regions of human protein-coding genes II: the importance of mRNA secondary structure in assessing the functionality of 3¢ UTR variants.
Human Genetics
120:
301–333.
|
|
|
Esquela-Kerscher A and
Slack FJ
(2006)
Oncomirs–microRNAs with a role in cancer.
Nature Reviews. Cancer
6:
259–269.
|
|
|
Mirkin SM
(2007)
Expandable DNA repeats and human disease.
Nature
447:
932–940.
|
|
|
Schiffmann R
(2009)
Fabry disease.
Pharmacology & Therapeutics
122:
65–77.
|
|
|
Soifer HS,
Rossi JJ and
Sætrom P
(2007)
MicroRNAs in disease and potential therapeutic applications.
Molecular Therapy
15:
2070–2079.
|
|
|
van der Vliet HJJ and
Nieuwenhuis EE
(2007)
IPEX as a result of mutations in FOXP3.
Clinical and Developmental Immunology
2007:
89017.
|
